1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • How do CARs work? Early insights from recent clinical studies targeting CD19
    Journal Article

    Davila, M. L.; Brentjens, R.; Wang, X. Y.; Riviere, I.; Sadelain, M.
    OncoImmunology (2012)

    Fulltext@MSK | Save
  • Phase i clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma
    Journal Article

    Konner, J.; Grisham, R. N.; Park, J.; O'Connor, O. A.; Cropp, G.; Johnson, R.; Hannah, A. L.; Hensley, M. L.; Sabbatini, P.; Mironov, S.; more...
    Investigational New Drugs (2012)

    Fulltext@MSK | Save
  • Synchronous resection of primary and liver metastases for neuroendocrine tumors
    Journal Article

    Gaujoux, S.; Gonen, M.; Tang, L.; Klimstra, D.; Brennan, M. F.; D'Angelica, M.; DeMatteo, R.; Allen, P. J.; Jarnagin, W.; Fong, Y.
    Annals of Surgical Oncology (2012)

    Fulltext@MSK | Save
  • HSP70 inhibitor, YK5, synergizes with chemotherapeutic agents and prevents chemoresistance in acute myelogenous leukemia (AML)
    Meeting Abstract

    Sharma, K. K.; Rico, J. F.; Becker, M. W.; Roboz, G. J.; Chiosis, G.; Guzman, M. L.
    Blood (2012)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in patients with acute myeloid leukemia (AML) in complete remission (CR)
    Meeting Abstract

    Rosenblat, T. L.; Frattini, M. G.; Chanel, S. M.; Dao, T.; Bernal, Y.; Jurcic, J. G.; Zhang, R.; Simancek, P.; Tallman, M. S.; Scheinberg, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • L3MBTL1: A polycomb protein at the node of crosstalk between the BMP4 and hippo signaling pathways in erythropoiesis
    Meeting Abstract

    Perna, F.; Vu, L. P.; Themeli, M.; Hoya-Arias, R. ; Liu, F.; Wang, L.; Gurvich, N.; Hricik, T.; Papapetrou, E. P.; Moore, M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Direct RNA target analysis identifies signatures that define Msi2's role in sustaining HSC cell fate
    Meeting Abstract

    Park, S. M.; Deering, R.; Lu, Y. H.; Tivnan, P.; Shenoy, V.; Lianoglou, S.; Al-Shahrour, F.; Leslie, C.; Ebert, B. L.; Lengner, C.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Impact of the conditioning chemotherapy on outcomes in adoptive T cell therapy: Results from a phase I clinical trial of autologous CD19-targeted T cells for patients with relapsed CLL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Stefanski, J.; He, Q.; Taylor, C.; Olszewska, M.; Wasielewska, T.; Bartido, S.; Davila, M. L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Anti-apoptotic Bcl2 and Bcl-Xl proteins involved in stroma-induced drug tolerance to Hsp70 and Hsp90 inhibitors in leukemia and B-cell lymphoma
    Meeting Abstract

    Lopes, E. C.; Correa, F. M.; Shen, L. B.; Shieh, J.H.; Taldone, T.; Chiosis, G.; Moore, M. A. S.
    Blood (2012)

    Fulltext@MSK | Save
  • Combination therapy using JAK2 and HSP90 inhibitors increased efficacy in myelofibrosis in vivo
    Meeting Abstract

    Levine, R. L.; Koppikar, P.; Marubayashi, S.; Bhagwat, N.; Taldone, T.; Park, C. Y.; Chiosis, G.
    Blood (2012)

    Fulltext@MSK | Save